...
机译:经皮冠状动脉介入与冠状动脉旁路移植在无保护左主冠状动脉狭窄中
Nanchang Univ Affiliated Hosp 2 Dept Cardiovasc Med 1st Mingde Rd Nanchang Jiangxi Peoples R;
Nanchang Univ Affiliated Hosp 2 Dept Cardiovasc Med 1st Mingde Rd Nanchang Jiangxi Peoples R;
Nanchang Univ Affiliated Hosp 2 Dept Cardiovasc Med 1st Mingde Rd Nanchang Jiangxi Peoples R;
Nanchang Univ Affiliated Hosp 2 Dept Cardiovasc Med 1st Mingde Rd Nanchang Jiangxi Peoples R;
Nanchang Univ Affiliated Hosp 2 Dept Cardiovasc Med 1st Mingde Rd Nanchang Jiangxi Peoples R;
Nanchang Univ Affiliated Hosp 2 Jiangxi Key Lab Mol Med Nanchang Jiangxi Peoples R China;
Nanchang Univ Affiliated Hosp 2 Dept Pharm Nanchang Jiangxi Peoples R China;
Nanchang Univ Affiliated Hosp 2 Dept Cardiovasc Med 1st Mingde Rd Nanchang Jiangxi Peoples R;
Nanchang Univ Affiliated Hosp 2 Dept Cardiovasc Med 1st Mingde Rd Nanchang Jiangxi Peoples R;
Unprotected left main coronary artery stenosis; Percutaneous coronary intervention; Coronary artery bypass grafting; Meta-analysis;
机译:经DELTA注册中心对未保护的左主冠状动脉的经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗眼中/中轴病变的长期临床结果:一个多中心注册中心,评估经皮冠状动脉介入治疗与冠状动脉旁路移植术对左主要治疗方法
机译:支架置入术与冠状动脉旁路移植术治疗无保护的左主冠状动脉疾病的长期安全性和有效性:MAIN-COMPARE(无保护的左主冠状动脉狭窄的血运重建:经皮冠状动脉血管成形术与手术血运重建的比较)的5年结果。
机译:经皮冠状动脉介入与冠状动脉旁路移植在无保护左主冠状动脉狭窄中
机译:Euroscore和我们的风险预测模型用于冠状动脉旁路冠状动脉左右疾病的冠状动脉旁路移植的外科和全因导致死亡率
机译:体外循环冠状动脉搭桥术与体外循环冠状动脉搭桥术:重要的是-手术量或特异性/专长?
机译:第二代药物洗脱支架冠状动脉搭桥术与经皮冠状动脉介入治疗多支血管和未保护左主干冠脉疾病的结果
机译:经皮冠状动脉介入治疗相对于未保护的左主干动脉冠状动脉/中轴病变的经皮冠状动脉旁路移植术的长期临床结果来自DELTA注册中心的多中心注册中心,评估经皮冠状动脉介入治疗与左冠状动脉旁路移植术的比较